The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease

Decreased kidney function is an important risk factor for cardiovascular disease (CVD). However, assessing risk of CVD may be difficult when there is a gap between creatinine- and cystatin C-based estimated glomerular filtration rate (eGFR). We studied the association of the difference in eGFRs with major adverse cardiovascular events (MACE) in patients with chronic kidney disease (CKD).

Source: Atherosclerosis - August 27, 2021 Category: Cardiology Authors: Hyoungnae Kim, Jung Tak Park, Joongyub Lee, Ji Yong Jung, Kyu-Beck Lee, Yeong-Hoon Kim, Tae-Hyun Yoo, Shin-Wook Kang, Kyu Hun Choi, Kook-Hwan Oh, Curie Ahn, Seung Hyeok Han, KNOW-CKD investigators Source Type: research